Lmr Partners LLP Prothena Corp Public LTD CO Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Lmr Partners LLP holds 18,000 shares of PRTA stock, worth $269,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,000Holding current value
$269,100% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
198Shares Held
44.5MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$173 Million7.5% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$76.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$57.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$55.1 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$33.4 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $701M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...